Identification of inflammatory markers as indicators for disease progression in primary Sjögren syndrome
Yan Li1,2,3,#, Jimin Zhang1,2,3,#, Xiaoyan Liu4, Kumar Ganesan5, Guixiu Shi1,2,3
European Cytokine Network, Vol.35, No.1, pp. 1-12, 2024, DOI:10.1684/ecn.2024.0496
Abstract Primary Sjögren syndrome (pSS) is a systemic autoimmune disorder that affects various systems in the body, resulting in symptoms such as dry eyes and mouth, pain, and fatigue. Inflammation plays a critical role in pSS and its associated complications, with chronic inflammation being a common occurrence in patients with pSS. This review of the literature highlights inflammatory markers that could serve as indicators to predict disease progression in pSS. Results: Laboratory markers are frequently and significantly increased in pSS patients, including erythrocyte sedimentation rate, C-reactive protein, complement proteins, S100 proteins, cytokines (IFNs, CD40 ligand, soluble CD25, More >